News for Epsilon Healthcare Limited (HDRPF)

Epsilon Healthcare Limited announces that effective from 22 November 2023 the Company's Registered Office and Principal Place of business will be changed as follows: New address and contact details:...

Research finds finds most Australians are still medicating with illicit cannabis, although numbers accessing legal prescription have risen.

The first of new products is set to be delivered by the end of FY23.

The competition to become the world’s supplier of medicinal cannabis is hotting up. Australian weed companies are getting into the action.

Missouri and Maryland have just voted to legalise weed and Arkansas, North Dakota and South Dakota could be next.

Read the ultimate guide on ASX cannabis stocks, companies and pricing. Gain advice to uncover market conditions and investing opportunities.

Researchers say data shows transition from illicit to legal use of cannabis, with medicinal users up 34.5% since 2018.

ECS Botanics Holdings has struck a deal worth more than $4.9 million to supply cannabis medicinal cannabis resin to Cannvalate.

Below is a recap of the main news related to the cannabis industry and markets for the week of September 6, 2021.